Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75,462,362
-
Total 13F shares
-
18,520,543
-
Share change
-
-146,338
-
Total reported value
-
$57,779,293
-
Put/Call ratio
-
2.8%
-
Price per share
-
$3.12
-
Number of holders
-
55
-
Value change
-
-$416,309
-
Number of buys
-
40
-
Number of sells
-
13
Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2023
As of 30 Jun 2023,
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,520,543 shares.
The largest 10 holders included
Sofinnova Investments, Inc., Novo Holdings A/S, SECTORAL ASSET MANAGEMENT INC, Alyeska Investment Group, L.P., Blackstone Inc., VANGUARD GROUP INC, Velan Capital Investment Management LP, Tekla Capital Management LLC, Nan Fung Group Holdings Ltd, and UBS OCONNOR LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.